Skip to main content
. 2024 Sep 16;46:101070. doi: 10.1016/j.lanepe.2024.101070

Fig. 2.

Fig. 2

Swimmer plot reporting the MSC test results over time along with lung cancer diagnosis and mortality. For the 125 patients who developed incident lung tumors during the BioMILD study, the MSC test results at annual recall and at cancer diagnosis were considered. Overall mortality and lung cancer-specific mortality are indicated with black lines starting from the time of lung cancer diagnosis.